"invasive bladder cancer" trang 2 - tải miễn phí từ tailieunhanh
Metastatic non-muscle invasive bladder cancer with meningeal carcinomatosis: Case report of an unexpected response

Metastatic non-muscle invasive bladder cancer with meningeal carcinomatosis: Case report of an unexpected response
4    71    1
Optimal schedule of bacillus calmette-guerin for non-muscle-invasive bladder cancer: A meta-analysis of comparative studies

Optimal schedule of bacillus calmette-guerin for non-muscle-invasive bladder cancer: A meta-analysis of comparative studies
15    34    1
Pre-clinical and clinical studies on the role of RBM3 in muscle-invasive bladder cancer: Longitudinal expression, transcriptome-level effects and modulation of chemosensitivity

Pre-clinical and clinical studies on the role of RBM3 in muscle-invasive bladder cancer: Longitudinal expression, transcriptome-level effects and modulation of chemosensitivity
15    16    1
Immune inactivation by VISTA predicts clinical outcome and therapeutic benefit in muscle-invasive bladder cancer

Immune inactivation by VISTA predicts clinical outcome and therapeutic benefit in muscle-invasive bladder cancer
11    1    1
The optimal intravesical maintenance chemotherapy scheme for the intermediate-risk group non-muscle-invasive bladder cancer

The optimal intravesical maintenance chemotherapy scheme for the intermediate-risk group non-muscle-invasive bladder cancer
7    3    1
Low-dose Bacillus Calmette-Guerin versus full-dose for intermediate and high-risk of non-muscle invasive bladder cancer: A Markov model

Low-dose Bacillus Calmette-Guerin versus full-dose for intermediate and high-risk of non-muscle invasive bladder cancer: A Markov model
8    39    1
RNAseq expression patterns of canine invasive urothelial carcinoma reveal two distinct tumor clusters and shared regions of dysregulation with human bladder tumors

RNAseq expression patterns of canine invasive urothelial carcinoma reveal two distinct tumor clusters and shared regions of dysregulation with human bladder tumors
12    74    0
B4GALT1 expression predicts prognosis and adjuvant chemotherapy benefits in muscleinvasive bladder cancer patients

B4GALT1 expression predicts prognosis and adjuvant chemotherapy benefits in muscleinvasive bladder cancer patients
9    73    1
Distinct mutation profiles between primary bladder cancer and circulating tumor cells warrant the use of circulating tumors cells as cellular resource for mutation follow-up

Distinct mutation profiles between primary bladder cancer and circulating tumor cells warrant the use of circulating tumors cells as cellular resource for mutation follow-up
9    33    1
Prediction of pathological response following neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer: The PRE-PREVENCYS trial

Prediction of pathological response following neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer: The PRE-PREVENCYS trial
11    44    1
Young age increases the risk of lymphnode metastasis in patients with muscleinvasive bladder urothelial carcinoma

Young age increases the risk of lymphnode metastasis in patients with muscleinvasive bladder urothelial carcinoma
6    34    1
MALBAC-based chromosomal imbalance analysis: A novel technique enabling effective non-invasive diagnosis and monitoring of bladder cancer

MALBAC-based chromosomal imbalance analysis: A novel technique enabling effective non-invasive diagnosis and monitoring of bladder cancer
9    68    1
Programmed death-ligand 1 (PD-L1) characterization of circulating tumor cells (CTCs) in muscle invasive and metastatic bladder cancer patients

Programmed death-ligand 1 (PD-L1) characterization of circulating tumor cells (CTCs) in muscle invasive and metastatic bladder cancer patients
11    34    1
Prediction of non-muscle invasive bladder cancer outcomes assessed by innovative multimarker prognostic models

Prediction of non-muscle invasive bladder cancer outcomes assessed by innovative multimarker prognostic models
9    54    1
Prognostic relevance of positive urine markers in patients with negative cystoscopy during surveillance of bladder cancer

Prognostic relevance of positive urine markers in patients with negative cystoscopy during surveillance of bladder cancer
11    56    1
Current and recent clinical trials for perioperative systemic therapy for muscle invasive bladder cancer: A systematic review

Current and recent clinical trials for perioperative systemic therapy for muscle invasive bladder cancer: A systematic review
15    56    1
Evaluating the impact of 18F-FDG-PET-CT on risk stratification and treatment adaptation for patients with muscleinvasive bladder cancer (EFFORT-MIBC): A phase II prospective trial

Evaluating the impact of 18F-FDG-PET-CT on risk stratification and treatment adaptation for patients with muscleinvasive bladder cancer (EFFORT-MIBC): A phase II prospective trial
7    56    1
Glycoprotein α-Subunit of Glucosidase II (GIIα) is a novel prognostic biomarker correlated with unfavorable outcome of urothelial carcinoma

Glycoprotein α-Subunit of Glucosidase II (GIIα) is a novel prognostic biomarker correlated with unfavorable outcome of urothelial carcinoma
16    17    1
Clinical outcomes of muscle invasive bladder Cancer according to the BASQ classification

Clinical outcomes of muscle invasive bladder Cancer according to the BASQ classification
8    54    0
An orthotopic xenograft model for high-risk non-muscle invasive bladder cancer in mice: Influence of mouse strain, tumor cell count, dwell time and bladder pretreatment

An orthotopic xenograft model for high-risk non-muscle invasive bladder cancer in mice: Influence of mouse strain, tumor cell count, dwell time and bladder pretreatment
12    56    1